Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...

A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...

EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat cerebellum.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

The facility will be built to meet SFDA, FDA, EMA, and BMBL requirements and will include a fully integrated digital ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...